XML 10 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 169.7 $ 488.3
Accounts receivable, net 507.2 492.0
Inventories 1,175.9 968.3
Other current assets 300.2 215.6
Total current assets 2,153.0 2,164.2
Property, plant and equipment, net 656.6 599.7
Goodwill 1,443.8 582.6
Intangible assets, net 1,024.3 330.5
Operating lease assets 136.2 91.7
Deferred tax assets 303.2 297.2
Other long-term assets 185.5 184.0
Total assets 5,902.6 4,249.9
Current liabilities:    
Current portion of long-term debt 26.4 121.2
Accounts payable 220.3 202.7
Deferred revenue and customer advances 501.9 400.0
Other current liabilities 555.9 478.2
Total current liabilities 1,304.5 1,202.1
Long-term debt 2,132.0 1,160.3
Long-term deferred revenue and customer advances 93.9 91.5
Deferred tax liabilities 178.5 67.7
Operating lease liabilities 111.3 74.8
Accrued pension 79.6 76.6
Other long-term liabilities 178.3 163.6
Total liabilities 4,078.1 2,836.6
Commitments and contingencies (Note 16)
Redeemable noncontrolling interests 17.5 18.7
Shareholders' equity:    
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding 0.0 0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 182,170,700 and 175,943,705 shares issued and 151,391,821 and 145,164,826 shares outstanding at June 30, 2024 and December 31, 2023, respectively 1.8 1.7
Treasury stock, at cost, 30,778,879 shares at June 30, 2024, and December 31, 2023, respectively (1,237.2) (1,237.2)
Additional paid-in capital 701.3 282.9
Retained earnings 2,367.3 2,323.8
Accumulated other comprehensive (loss) income, net of tax (44.0) 6.0
Total shareholders' equity attributable to Bruker Corporation 1,789.2 1,377.2
Noncontrolling interests in consolidated subsidiaries 17.8 17.4
Total shareholders' equity 1,807.0 1,394.6
Total liabilities, redeemable noncontrolling interests and shareholders' equity $ 5,902.6 $ 4,249.9